Advances in Pulmonary Drug Delivery, Volume II

Dear Colleagues,

Drug delivery to the lungs by oral inhalation represents an attractive non-invasive administration route for therapeutics. In addition to locally acting drugs, molecules  that are intended to produce a systemic effect can be delivered via the pulmonary route. Pulmonary delivery requires the patient to inhale an aerosol of the therapeutics agent. For the successful delivery via oral inhalation, formulation into an appropriate inhalable dosage form with a sufficient stability is critical. It is also essential that the formulation is paired with a device, which generates an aerosol of the appropriate particle/droplet size to ensure deposition into the desired regions of the respiratory tract.

This Special Issue attempts to highlight current research activities in the areas of inhaler device development; formulation development approaches for inhaled drugs; in vitro and in silico models of pulmonary drug deposition and drug disposition; and advanced delivery options for complex drugs, such as vaccines, antibiotics, nucleic acids, or peptides, to or via the lungs.

Prof. Dr. Carsten Ehrhardt
Dr. Ayca Yildiz-Pekoz
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.